Annals ofRheumatoid Arthritis

Volume: 6 - Number: 56 - March 15, 2008

Outstanding

Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy

Citrullination in extra-articular manifestations of rheumatoid arthritis

Infections during tumour necrosis factor- blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients

Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration

Basic Sciences

Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy

Citrullination in extra-articular manifestations of rheumatoid arthritis

Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-B- and p38 MAPK-dependent signalling pathways

Case report

Unstable diabetes in a patient receiving anti-TNF- for rheumatoid arthritis

Clinic

A clinical trial of specialist footwear for patients with rheumatoid arthritis

Ages of onset suggestive of genetic anticipation in rheumatoid arthritis multicase sibships can be explained by observational bias

Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis

Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus

Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study

Infections during tumour necrosis factor- blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients

Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration

Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis

The –308 tumour necrosis factor- gene polymorphism predicts therapeutic response to TNF-blockers in rheumatoid arthritis and spondyloarthritis patients

The impact of a coordinated transitional care programme on adolescents with juvenile idiopathic arthritis

Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns

Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease

Editorial

Lymphoma and rheumatoid arthritis—again

Ultrasonography in rheumatology: developing its potential in clinical practice and research

Very early ‘Rheumatoid’ arthritis cohorts: limited by selection

Matters arising

Comment on ‘Drug-related pulmonary problems in patients with rheumatoid arthritis’

Pulmonary adverse events with leflunomide—myth or reality?

Reply to comment on ‘Drug-related pulmonary problems in patients with rheumatoid arthritis’ by Yazici and Yazici and ‘Pulmonary adverse events with Leflunomide—myth or reality?’ by Balakrishnan and Dasgupta

Review

Therapeutic status of radiosynoviorthesis of the knee with yttrium [90Y] colloid in rheumatoid arthritis and related indications